SCHEMBL735234

SCHEMBL735234

CCOC(=O)CC1(O)C(=O)Nc2ccccc21

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.59
TDO2 P48775 1/20 0.59
ALDH1A1 P00352 4/20 0.58
SMN1; SMN2 Q16637 3/20 0.58
LMNA P02545 3/20 0.58
GAA P10253 1/20 0.57
MAPT P10636 2/20 0.57
NPSR1 Q6W5P4 1/20 0.57
HTT P42858 1/20 0.53
ATM Q13315 1/20 0.52
USP2 O75604 1/20 0.51
PKM P14618 1/20 0.51
HPGD P15428 1/20 0.51
TSHR P16473 1/20 0.51
HSD17B10 Q99714 1/20 0.51
KDM4E B2RXH2 1/20 0.50
MTOR P42345 1/20 0.46
RICTOR Q6R327 1/20 0.46
RPTOR Q8N122 1/20 0.46
MAPKAP1 Q9BPZ7 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7607750 0.85 SMN1; SMN2 (0.48) IDO1TDO2ALDH1A1SMN1; SMN2LMNA
SCHEMBL12747117 0.84 PDK2 (0.46) IDO1TDO2ALDH1A1SMN1; SMN2LMNA
SCHEMBL27780994 0.81 USP2 (0.55) IDO1ALDH1A1LMNAMAPTHTT
SCHEMBL699106 0.81 IDO1 (0.48) IDO1TDO2ALDH1A1SMN1; SMN2LMNA
SCHEMBL25435983 0.80 IDO1 (0.77) IDO1TDO2ALDH1A1SMN1; SMN2LMNA
SCHEMBL1460831 0.80 SMN1; SMN2 (0.70) IDO1TDO2ALDH1A1SMN1; SMN2LMNA
SCHEMBL8056975 0.77 GAA (0.61) IDO1TDO2ALDH1A1SMN1; SMN2LMNA
SCHEMBL734639 0.77 IDO1 (0.47) IDO1ALDH1A1SMN1; SMN2LMNAMAPT
SCHEMBL18552440 0.77 ALDH1A1 (0.43) IDO1TDO2ALDH1A1SMN1; SMN2LMNA
SCHEMBL27780980 0.77 ALDH1A1 (0.47) IDO1ALDH1A1LMNAGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101516844-B 4-heteroaryl substituted 1-aminocyclohexane-1-and cyclohexene-1-derivatives having activity on opioid receptor systems GRUENENTHAL GMBH 2013-12-11 CN disclosed
US-8138187-B2 Substituted heteroaryl derivatives GRUENENTHAL GMBH (DE) 2012-03-20 US disclosed
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES GRUNENTHAL GMBH (DE) 2010-01-14 US disclosed
CN-101516844-A 4-heteroaryl substituted 1-aminocyclohexane-1-and cyclohexene-1-derivatives having activity on opioid receptor systems GRUENENTHAL GMBH (DE) 2009-08-26 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES CYP3A43, HMGCR, ABCG2 IDO1 2394/4885TDO2 1393/4885ALDH1A1 3171/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.